| |
|
|
|
Royal Pharmaceutical Society , Moller Centre, Churchill College, University of Cambridge, Cambridge
Sunday 15th May 2011 - Thursday 19th May 2011
For programme details, please follow the link to our website: http://www.rpharms.com/development/pkpd-course.asp
|
|
|
|
|
|
|
|
Organized by:
|
|
Royal Pharmaceutical Society in partnership with the Swedish Academy of Pharmaceutical Sciences |
|
|
Invited Speakers:
|
|
Dr Johan Gabrielsson is a Senior Principal Scientist at AstraZeneca R&D Mölndal. He is author of the book ‘Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications’ 4th ed. (2006). He is academically affiliated with the Department of Pharmacology, Gothenburg University, Sweden. He has conducted numerous workshops on biological (PK/PD) data analysis within and outside the pharmaceutical industry. Dr Daniel Weiner is a Senior Vice President and CTO at Pharsight Corporation. He is co-author of the book ‘Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications’ 4th ed. (2006). He has conducted numerous workshops on biological (PK/PD) data analysis and has served as an expert consultant to the FDA.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
Fees: £2,415 for members of RPSGB or Swedish Academy, £2,565 for non-members (both of these fees are inclusive of 4 nights’ accommodation, meals and refreshments, a welcome reception, social programme and a resource pack with full course documentation.) £1,995 for members of RPSGB or Swedish Academy (no accommodation or evening meal included) £2,150 for non-members (no accommodation or evening meal included) Delegates registering before Monday 14 February 2011 will receive a complementary copy of the course textbook “Pharmacokinetic/Pharmacodynamic Data Analysis: Concepts and Applications” (4th Edition, Swedish Pharmaceutical Press 2006) Any delegates registering after this date must purchase a copy of the textbook before the beginning of the course.
|
|
|
E-mail:
|
|
events@rpharms.com
|
|
|
|
|
|
|
|
|